Head-to-Head Trial in Relapsing MS

• by Kathryn Wighton

• July 7, 2026

Oculomics: Beyond the Buzzword

Joseph J. Pizzimenti, OD, FAAO, FORS, discusses the capabilities of oculomics in retina and neuro-ophthalmology,

• by Sarah Fackler, managing editor, Optometric Management

• June 17, 2026

• 6 min

HLA-DRB1*15:01 drives sex- and age-dependent microglial immune phenotypes and neuroimmune signaling

• by Elsa M. Reyes-Reyes, Dhanalakshmi Chinnasamy, Michael D. Trial, Fernando Fernandez, Vincent D. Nguyen, Qianying He, Angel-Grace Leslie, Jessica Begay, Jessica Triplett, David Bradford, Carolina Figueroa, Jean P. Wiegand, Kathleen E. Rodgers

• June 16, 2026

A combined therapeutic approach: extracorporeal shock wave therapy and botulinum toxin in multiple sclerosis-related spasticity

• by Arianna Sartori, Anna Favero, Laura Mazzari, Giulia Mazzon, Alessio Bratina, Antonio Bosco, Marinella Tomaselli, Paolo Manganotti

• June 16, 2026